PET/MRI in Primary Staging of Laryngeal Cancer
Examination with PET/ MRI for patients with laryngeal cancer.
Imaging with PET/MRI is useful for primary staging of laryngeal cancer, according to a study in the European Journal of Radiology.
Researchers from Italy sought to assess the clinical impact of PET/MRI examination on patients with histologically proven laryngeal cancer, and their staging and treatment planning.
Sixteen patients underwent whole body PET/CT followed by a dedicated head/neck PET/MRI. Two blinded groups evaluated the data: metabolic (SUV and MTV), diffusion (ADC) and perfusion (Ktrans, Ve, kep, and iAUC) maps were obtained by positioning regions of interest (ROIs). Tumoral local extension assessed on PET/MRI was compared to endoscopic findings.
The results showed a good interobserver agreement in anatomical location and local extension of PET/MRI lesions. “PET/CT SUV measures highly correlate with ones derived by PET/MRI (eg, pâ =â 0.96 for measures on VOI),” the authors wrote. “Significant correlations among metabolic, diffusion and perfusion parameters have been detected.” The researchers noted that PET/MRI had a relevant clinical impact, confirming endoscopic findings (six cases), helping treatment planning (nine cases), and modifying endoscopic primary staging (one case).
The researchers concluded that use of PET/MRI in primary staging of laryngeal cancer allowed simultaneous collection of metabolic and functional data and conditioning the therapeutic strategies.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
